Thought Leadership
Article | July 23, 2015
Read more
How To Avoid FDA Regulation Of Your Mobile Medical App
Med Devices Online
Blog | July 22, 2015
Amgen v. Sandoz: Federal Circuit Weighs In on the BPCIA Riddle
Fish & Richardson
Read more
Blog | July 21, 2015
Exclusion of Patentee's Damages Expert Not Sufficient to Justify Granting Summary Judgment
Fish & Richardson
Read more
Blog | July 21, 2015
Claims Should Be Broadly Construed to Include Their Full Plain Meaning Where There Is No Disclaimer or Lexicography
Fish & Richardson
Read more
Blog | July 10, 2015
NDCA bars negative NPE terminology; allows product revenue and settlement agreements
Fish & Richardson
Read more
Blog | July 08, 2015
Software Claim Addressing Concepts Long Known in Other Fields and Lacking Other Inventive Concept Is Not Patent Eligible
Fish & Richardson
Read more
Blog | July 07, 2015
Read more
FDA's Latest ANDA Guidance: Patent Carve Outs Become a Guessing Game
Pharmaceutical Compliance Monitor
Blog | July 06, 2015
35 U.S.C. § 101 Practice in the Eastern District of Texas
Fish & Richardson
Read more
Blog | July 03, 2015
DDE excludes revenues & profits due to failed apportionment, allows do-over
Fish & Richardson
Read more
Blog | July 02, 2015
Nevada court imposes 3X post-judgment royalty in lieu of injunction
Fish & Richardson
Read more
Blog | July 01, 2015
Utah court allows evidence of minimum royalty payments by third parties
Fish & Richardson
Read more